Literature DB >> 31741197

The NLRP3 Inflammasome and Its Role in Sepsis Development.

Lucinéia Gainski Danielski1, Amanda Della Giustina1, Sandra Bonfante1, Tatiana Barichello2,3, Fabricia Petronilho4.   

Abstract

The pathophysiology of sepsis is extremely complex. During this disease, the exacerbation of the inflammatory response causes oxidative stress, alterations in mitochondrial energy dynamics, and multiple organ failure. Some studies have highlighted the important role of the NLRP3 inflammasome in sepsis. This inflammasome is a macromolecular protein complex that finely regulates the activation of caspase-1 and the production and secretion of potent pro-inflammatory cytokines such as IL-1β and IL-18. In this review, we elucidate evidences to understand the connection between sepsis development and the NLRP3 inflammasome, the most widely investigated member of this class of receptor.

Entities:  

Keywords:  NLRP3; inflammasome; organ failure; sepsis

Mesh:

Substances:

Year:  2020        PMID: 31741197     DOI: 10.1007/s10753-019-01124-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  63 in total

Review 1.  Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3.

Authors:  Seema Patel
Journal:  Biomed Pharmacother       Date:  2017-06-06       Impact factor: 6.529

2.  Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.

Authors:  Yu-Chang Wang; Qin-Xin Liu; Qiang Zheng; Tao Liu; Xi-E Xu; Xing-Hua Liu; Wei Gao; Xiang-Jun Bai; Zhan-Fei Li
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

Review 3.  Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies.

Authors:  B Beutler; X Du; A Poltorak
Journal:  J Endotoxin Res       Date:  2001

Review 4.  The Connections Among Autophagy, Inflammasome and Mitochondria.

Authors:  Isabel de Lavera; Ana Delgado Pavon; Marina Villanueva Paz; Manuel Oropesa-Avila; Mario de la Mata; Elizabet Alcocer-Gomez; Juan Garrido-Maraver; David Cotan; Monica Alvarez-Cordoba; Jose A Sanchez-Alcazar
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 5.  Recent advances in inflammasome biology.

Authors:  David E Place; Thirumala-Devi Kanneganti
Journal:  Curr Opin Immunol       Date:  2017-11-10       Impact factor: 7.486

6.  Syneilesis palmata (Thunb.) Maxim. extract attenuates inflammatory responses via the regulation of TRIF-dependent signaling and inflammasome activation.

Authors:  Ji-Won Han; Do-Wan Shim; Eun-Jeong Shim; Myong-Ki Kim; Yong-Kook Shin; Su-Bin Kwak; Sushruta Koppula; Tack-Joong Kim; Tae-Bong Kang; Kwang-Ho Lee
Journal:  J Ethnopharmacol       Date:  2015-03-06       Impact factor: 4.360

Review 7.  Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses.

Authors:  Young-Su Yi
Journal:  Immunology       Date:  2017-07-31       Impact factor: 7.397

8.  NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.

Authors:  Michael A Katsnelson; Kristen M Lozada-Soto; Hana M Russo; Barbara A Miller; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-11       Impact factor: 4.249

9.  Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.

Authors:  Feng Xu; Feng Wang; Taoqun Wen; Wentao Sang; Dejian Wang; Nan Zeng
Journal:  Immunopharmacol Immunotoxicol       Date:  2017-08-01       Impact factor: 2.730

10.  Hyperin protects against LPS-induced acute kidney injury by inhibiting TLR4 and NLRP3 signaling pathways.

Authors:  Gong Chunzhi; Li Zunfeng; Qin Chengwei; Bu Xiangmei; Yu Jingui
Journal:  Oncotarget       Date:  2016-12-13
View more
  38 in total

Review 1.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

2.  Cell-free fat extract protects septic lethality via restraining NLRP3 inflammasome activation.

Authors:  Dingyu Wu; Xizhe Li; Xiangsheng Wang; Dan Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 3.  Reprogramming Macrophage Metabolism and its Effect on NLRP3 Inflammasome Activation in Sepsis.

Authors:  Ruiheng Luo; Xizhe Li; Dan Wang
Journal:  Front Mol Biosci       Date:  2022-06-29

4.  The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis.

Authors:  Chia George Hsu; Camila Lage Chávez; Chongyang Zhang; Mark Sowden; Chen Yan; Bradford C Berk
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

5.  Suppression of NOD-like receptor protein 3 inflammasome activation and macrophage M1 polarization by hederagenin contributes to attenuation of sepsis-induced acute lung injury in rats.

Authors:  Lin Wang; Min Zhao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 6.  Redox Signaling from Mitochondria: Signal Propagation and Its Targets.

Authors:  Petr Ježek; Blanka Holendová; Lydie Plecitá-Hlavatá
Journal:  Biomolecules       Date:  2020-01-06

7.  ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome.

Authors:  Xiao-Yan Wu; Jin-Yan Lv; Shi-Qing Zhang; Xin Yi; Zi-Wei Xu; Yuan-Xing Zhi; Bo-Xin Zhao; Jian-Xin Pang; Ken Kin Lam Yung; Shu-Wen Liu; Ping-Zheng Zhou
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

8.  Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation.

Authors:  Chi-Han Huang; Shu-Chi Wang; I-Chen Chen; Yi-Ting Chen; Po-Len Liu; Shih-Hua Fang; Shu-Pin Huang; Hsin-Chih Yeh; Ching-Chih Liu; Po-Yen Lee; Tzu-Chieh Lin; Wei-Chung Cheng; Chia-Cheng Su; Hsin-En Wu; Yuan-Ru Chen; Chia-Yang Li
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

Review 9.  HDL and persistent inflammation immunosuppression and catabolism syndrome.

Authors:  Grant Barker; Julia R Winer; Faheem W Guirgis; Srinivasa Reddy
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

Review 10.  Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Authors:  Christopher B Ryder; Hannah C Kondolf; Meghan E O'Keefe; Bowen Zhou; Derek W Abbott
Journal:  J Mol Biol       Date:  2021-08-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.